Check Franchise Availability
Apply for Intra Life PCD Pharma Franchise Enquire on WhatsApp
Instant Franchise Enquiry | Whatsapp
Download Product List
Employee Complaint Form Pay Online Download Product List Download Profile
WhatsApp

Blog

  • Home
  • Blog
  • PETALIFE-IT Capsules: Pantoprazole 40mg + Itopride 150mg for GERD and Digestive Health

PETALIFE-IT Capsules: Pantoprazole 40mg + Itopride 150mg for GERD and Digestive Health

  • 29-09-2026

Quick Enquiry

Fill in your details and we’ll contact you.

 

Digestive discomfort, acid reflux, heartburn, bloating, and a feeling of fullness after meals are common gastrointestinal concerns. These symptoms may occur due to conditions such as gastroesophageal reflux disease (GERD), acid reflux, functional dyspepsia, and delayed gastric emptying. Management may involve medicines that address excessive stomach acid as well as medicines that support gastrointestinal motility.

PETALIFE-IT CAPS is a combination capsule containing Pantoprazole 40mg + Itopride 150mg. This combination brings together an acid-suppressing medicine and a prokinetic agent, making it relevant for patients experiencing acid-related symptoms along with certain dyspeptic or gastric-motility complaints.

What is PETALIFE-IT CAPS?

 

PETALIFE-IT CAPS contains two active pharmaceutical ingredients:

  • Pantoprazole 40mg

  • Itopride 150mg

Pantoprazole belongs to the proton pump inhibitor (PPI) class and reduces the production of stomach acid. PPIs such as pantoprazole are commonly used in the management of GERD and acid-related upper gastrointestinal symptoms. Clinical guidelines also recognize PPIs as an effective treatment option for functional dyspepsia in appropriate patients.

Itopride is a prokinetic medicine that acts on gastrointestinal motility. It has been studied in functional dyspepsia and symptoms such as post-meal fullness and upper abdominal bloating.

Together, these ingredients provide a combination approach for patients who have both acid-related and motility-associated gastrointestinal symptoms.

PETALIFE-IT CAPS Composition

 

Each PETALIFE-IT capsule contains:

Pantoprazole 40mg + Itopride 150mg

The combination is supplied in a 10 × 10 capsule pack.

How Does PETALIFE-IT Work?

 

PETALIFE-IT combines two medicines with different but complementary actions.

Pantoprazole 40mg

Pantoprazole reduces gastric acid production by inhibiting the proton pumps responsible for acid secretion in the stomach. Reduced acid production can help manage acid-related symptoms such as heartburn and acid reflux.

Proton pump inhibitors are widely used for GERD, and clinical guidelines recommend PPI therapy for appropriate patients with typical GERD symptoms.

Itopride 150mg

Itopride is a prokinetic agent that influences gastrointestinal motility. Prokinetic medicines may be considered when symptoms are associated with impaired gastric movement or dyspeptic symptoms. Studies and clinical guidelines have evaluated itopride for symptoms including postprandial fullness, early satiety, and bloating.

Therefore, PETALIFE-IT combines acid suppression with support for gastrointestinal motility, depending on the patient's clinical condition and the healthcare professional's treatment plan.

What is PETALIFE-IT Used For?

 

Based on its composition and indicated uses, PETALIFE-IT CAPS may be prescribed for the management of:

1. Gastroesophageal Reflux Disease (GERD)

GERD occurs when stomach contents reflux into the esophagus and may cause symptoms such as heartburn and regurgitation. Acid suppression with PPIs is an established treatment approach for appropriate GERD patients.

2. Acid Reflux

Excessive or recurrent acid reflux can cause burning sensations and discomfort in the upper digestive tract. Pantoprazole helps reduce gastric acid production and is used in the management of acid-related conditions.

3. Functional Dyspepsia

Functional dyspepsia may involve symptoms such as upper abdominal discomfort, post-meal fullness, early satiety, bloating, or burning. PPIs and selected prokinetic medicines are among the treatment approaches considered for appropriate patients.

4. Bloating and Post-Meal Digestive Discomfort

Bloating can occur alongside functional dyspepsia and other upper gastrointestinal conditions. Itopride has been evaluated for dyspeptic symptoms including postprandial bloating and fullness.

5. Delayed Gastric Emptying

Delayed gastric emptying can contribute to symptoms such as fullness, bloating, nausea, and discomfort after eating. Prokinetic medicines may be considered in selected patients when impaired gastric motility is part of the clinical picture.

Key Features of PETALIFE-IT CAPS

 

  • Contains Pantoprazole 40mg + Itopride 150mg

  • Combines an acid-suppressing agent with a prokinetic agent

  • Supports management of acid-related gastrointestinal symptoms

  • Relevant to GERD and acid reflux management

  • Used in appropriate patients with functional dyspepsia

  • May help address symptoms associated with gastric-motility problems

  • Available in a convenient 10 × 10 capsule pack

Who Should Take PETALIFE-IT CAPS?

 

PETALIFE-IT CAPS should be taken only as directed by a qualified healthcare professional. The appropriate medicine and treatment duration depend on the patient's symptoms, medical history, diagnosis, other medicines, and individual response.

Patients should inform their healthcare professional about existing medical conditions and any medicines or supplements they are currently taking before starting treatment.

This product should not be self-medicated simply for recurring acidity or indigestion without identifying the underlying cause.

Frequently Asked Questions About PETALIFE-IT CAPS

 

What is PETALIFE-IT CAPS used for?

PETALIFE-IT CAPS contains Pantoprazole 40mg and Itopride 150mg and is indicated for conditions and symptoms including GERD, acid reflux, functional dyspepsia, bloating, and delayed gastric emptying.

What is the composition of PETALIFE-IT?

PETALIFE-IT contains Pantoprazole 40mg + Itopride 150mg.

How does Pantoprazole help?

Pantoprazole is a proton pump inhibitor that reduces gastric acid production and is commonly used for acid-related gastrointestinal conditions, including GERD.

What is the role of Itopride?

Itopride is a prokinetic agent that affects gastrointestinal motility and has been studied for symptoms associated with functional dyspepsia, including fullness and bloating.

Is PETALIFE-IT suitable for everyone with acidity?

Not necessarily. Recurrent acidity can have different causes. PETALIFE-IT should be used according to a healthcare professional's diagnosis and prescription.

What is the packing of PETALIFE-IT CAPS?

PETALIFE-IT CAPS is available in a 10 × 10 capsule packing.

Conclusion

 

PETALIFE-IT CAPS combines Pantoprazole 40mg and Itopride 150mg in a single formulation. Pantoprazole helps reduce gastric acid production, while Itopride provides a prokinetic component that may be relevant to gastrointestinal motility and dyspeptic symptoms.

With its combination approach, PETALIFE-IT CAPS is indicated for GERD, acid reflux, functional dyspepsia, bloating, and delayed gastric emptying, when prescribed as appropriate by a healthcare professional. Proper diagnosis and professional guidance are important for selecting the right treatment and duration of therapy.

Share With: